Document:

Exhibit
10.6

 

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

 

FORM
OF COMMON STOCK PURCHASE WARRANT

 

NESTBUILDER.COM
CORP.

 

	Warrant
    Shares: [_______]	Issue
    Date: February 4, 2022

 

THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________________ or his assigns
(the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, on or prior to the close of business on the five year anniversary of the Issue Date (the “Termination Date”)
but not thereafter, to purchase from Nestbuilder.com Corp., a Nevada corporation (the “Company”), up to [_____________________]
(________) shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock of the Company (“Common
Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined
in Section 3(b).

 

Section
1. Definitions. As used in this Warrant, the terms set forth in this Section 1 shall have the respective meanings assigned to
them in this Section 1.

 

“Business
Day” means any day except any Saturday, any Sunday or any day on which banking institutions in the State of New York are authorized
or required by law or other governmental action to close.

 

“Commission”
means the Securities and Exchange Commission.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

    	1

     

    

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).

 

Section
2. Vesting; Acceleration.

 

(a)
Vesting. The Warrant shall become vested and exercisable as follows: (i) one-fourth (1/4th) of the total number of Warrant Shares
shall vest and become exercisable on the one (1) year anniversary of the Issue Date; and (ii) thereafter, one-twelfth (l/12th) of the
total number of remaining Warrant Shares shall vest and become exercisable on each of the monthly anniversaries following the first one
(1) year anniversary of the Issue Date, in each case, so long as the Holder continues to be a service provider of the Company.

 

(b)
Acceleration upon Termination Due to Death or Disability The foregoing vesting schedule
notwithstanding, if the Holder’s continuous status as a service provider is terminated
due to the Holder’s death or Disability (as defined below) at any time prior to the expiration
of the vesting schedule set forth in Section 2(a) above, 100% of the total number of Warrant
Shares at the time subject to this Warrant but not otherwise vested shall automatically vest in full so that this Warrant shall, immediately
upon such termination, become exercisable for all of the Warrant Shares as
fully-vested shares and may be exercised for any or all of those Warrant Shares as vested
shares.

 

(c)
Acceleration upon Termination without “Cause”. The foregoing vesting
schedule notwithstanding, if the Holder’s continuous status as a service provider is terminated
by the Company without Cause (as defined below) at any time prior to the expiration of the vesting schedule set forth in Section 2(a)
above, 100% of the total number of Warrant Shares at the time subject to this Warrant but not otherwise vested shall automatically
vest in full so that this Warrant shall, immediately upon such termination without Cause, become exercisable for
all of the Warrant Shares as fully-vested shares and may be exercised for any or all of
those Warrant Shares as vested shares.

 

(d)
Acceleration upon a Fundamental Transaction.
The foregoing vesting schedule notwithstanding, upon the occurrence of a Fundamental Transaction (as defined below), 100% of the total
number of Warrant Shares at the time subject to this Warrant but not otherwise vested shall automatically vest in full so that this Warrant
shall, as of the date of the Fundamental Transaction, become exercisable for all of the Warrant Shares as fully-vested shares and may
be exercised for any or all of those Warrant Shares as vested shares.

 

(e)
“Cause” Definition. For purposes of this Agreement, “Cause” shall mean: (i)
Holder’s unauthorized misuse of the Company or a parent or subsidiary of the Company’s trade secrets or proprietary information,
(ii) Holder’s conviction of or plea of nolo contendere to a felony or a crime involving moral turpitude, (iii) Holder’s committing
an act of fraud against the Company or a parent or subsidiary of the Company or (iv) Holder’s gross negligence or willful misconduct
in the performance of his or her duties that has had or will have a material adverse effect on the Company or parent or subsidiary of
the Company’ reputation or business.

 

    	2

     

    

 

(f)
“Disability” Definition. For purposes of this Agreement, “Disability”
shall mean a Holder is unable to perform the duties of his or her customary position of employment by reason of any medically
determinable physical or mental impairment that can be expected to result in death or that can be expected to last for a continuous period
of not less than twelve (12) months. The Company may require such medical or other evidence as it deems necessary to judge the nature
and permanency of the Holder’s condition.

 

Section
3. Exercise.

 

(a)
Exercise of Warrant. To the extent vested pursuant to Section 2 above, exercise of
the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or before the Termination Date
by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered
Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy (or e-mail attachment) of
the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 3(d)(i) herein) following the
date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice
of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 3(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such
notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this
paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof.

 

(b)
Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $0.0925, subject to adjustment hereunder
(the “Exercise Price”).

 

    	3

     

    

 

(c)
Cashless Exercise. In lieu of exercising this Warrant pursuant to Section 3(b), if the fair market value of one Share is greater
than the Exercise Price (at the date of calculation as set forth below), then this Warrant may also be exercised, in whole or in part,
at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing (A-B) (X) by (A), where:

 

	(A)	 	=
    as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice
    of Exercise is (1) both executed and delivered pursuant to Section 3(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 3(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined
    in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the
    Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
    Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”) as of the
    time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular
    trading hours” on a Trading Day and is delivered within two (2) hours thereafter pursuant to Section 3(a) hereof or (iii) the
    VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
    Exercise is both executed and delivered pursuant to Section 3(a) hereof after the close of “regular trading hours” on
    such Trading Day;
	(B)	 	=
    the Exercise Price of this Warrant, as adjusted hereunder; and
	(X)	 	=
    the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if
    such exercise were by means of a cash exercise rather than a cashless exercise.

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and, for
purposes of Rule 144 promulgated under the Securities Act, the holding period of the Warrants being
exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to take any position contrary to this
Section 3(c).

 

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for trading on a Trading
Market and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (c) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for trading on a Trading
Market and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (c) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

    	4

     

    

 

Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 3(c) without any action on the part of the Holder.

 

(d)
Mechanics of Exercise.

 

i.
Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Company’s transfer agent (the “Transfer Agent”) to the Holder by crediting the account of the Holder’s
or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”)
if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and
otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee,
for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in
the Notice of Exercise by the date that is the earlier of (i) the earlier of (A) two (2) Trading Days after the delivery to the Company
of the Notice of Exercise and (B) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (ii) the number
of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the
“Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate
purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period following delivery of the Notice of Exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period”
means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

 

ii.
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.

 

iii.
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
3(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

    	5

     

    

 

iv.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.

 

v.
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that in the event Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto (the “Assignment Form”) duly executed by
the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all
fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.

 

vi.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.

 

(e)
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 3 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder’s Affiliates, such other Persons, “Attribution
Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder, its Affiliates and Attribution Parties shall
include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being
made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 3(e),
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 3(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates or Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
or Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to
any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 3(e), in determining the number of outstanding shares of Common Stock, a Holder
may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request
of a Holder, the Company shall within two Trading Days confirm orally or in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation”
shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The restriction described in this Section 3(e) may be revoked upon sixty-one (61) days
prior notice from the Holder to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 3(e) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

    	6

     

    

 

Section
4. Certain Adjustments.

 

(a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 4(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.

 

(b)
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 4(a) above, if at any time the Company grants,
issues or sells any security entitling the holder thereof (including pursuant to sales, grants, conversions, warrant exercises or other
issuances to the Holder as a result of this Warrant, prior transaction documents, or future transaction documents) to acquire Common
Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is convertible into
or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock (a “Common Stock Equivalent”)
or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock
(the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights,
the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant,
issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase
Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate
in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such
extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

(c)
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).

 

    	7

     

    

 

(d)
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock,
(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each
a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 3(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 3(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 4(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by
a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares
of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and
with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from
and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company” shall refer
instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the
Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.

 

    	8

     

    

 

(e)
Calculations. All calculations under this Section 4 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 4, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

(f)
Notice to Holder.

 

i.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 4, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period
commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly
set forth herein.

 

    	9

     

    

 

Section
5. Transfer of Warrant.

 

(a)
Transferability. This Warrant may be transferred by the Holder only with the written consent
of the Company to the transfer.

 

(b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 5(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

(c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.

 

(d)
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that:

 

i.
it is an “accredited investor” as defined in Regulation D of the Securities Act;

 

ii.
it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for
investment for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in
violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the
Securities Act;

 

iii.
it understands and acknowledges that this Warrant and the Warrant Shares to be issued upon exercise hereof are “restricted
securities” under the federal securities laws and may not be offered, sold, pledged or otherwise transferred expect (A)
pursuant to an exemption from registration under the Securities Act and, if the Company requests, upon delivery of an opinion of
counsel to such effect, in form and substance reasonably satisfactory to the Company or (B) pursuant to an effective registration
statement under the Securities Act, in each case in accordance with all applicable state securities laws and the securities laws of
other jurisdictions; and

 

    	10

     

    

 

iv.
it can bear the economic and financial risk of its investment for an indefinite period and has such knowledge and experience in
financial or business matters that it is capable of evaluating the merits and risks of the investment in the Warrant and the Warrant
Shares.

 

Section
6. Registration Rights. If at any time the Company shall determine to (x) prepare and file with the Commission a registration
statement for the sale of Common Stock or other equity securities of the Company, or (y) sell shares of Common Stock or other equity
securities of the Company in an underwritten offering pursuant to a registration statement filed with the Commission on Form S-3 (or
any successor form or other appropriate form promulgated under the Securities Act) for an offering to be made on a continuous or delayed
basis pursuant to Rule 415 promulgated under the Securities Act, in each case, either for its own account or for the account of other
holders of equity securities in the Company, the Company shall (i) promptly, but no less than fifteen (15) Business Days prior to the
anticipated filing date of the registration statement (in the case of clause (x) above) or such sale (in the case of clause (y) above),
give to each holder of Warrant Shares written notice thereof and (ii) subject to customary limitations (including, without limitation,
underwriter cutbacks) and receipt of customary information, representations and undertakings from the Holder, include in such registration
statement or sale, as applicable, all Warrant Shares specified in a written request or requests, made by the holders of the Warrant Shares
within five (5) Business Days after receipt of the notice from the Company described in clause (i) above. For the avoidance of doubt,
this Section 6 shall survive the exercise in full of this Warrant or, if this exercise shall have been exercised in part or in full prior
to such termination, the termination of this Warrant.

 

Section
7. Miscellaneous.

 

(a)
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 3(d)(i), except as expressly set forth in Section
4.

 

(b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.

 

(c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business
Day.

 

    	11

     

    

 

(d)
Authorized Shares.

 

The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its articles of incorporation, as amended, or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.

 

(e)
Governing Law; Venue. This Warrant shall be governed by and construed under the laws of the State of Nevada as applied
to agreements among Nevada residents, made and to be performed entirely within the State of Nevada. The Parties agree that any action
brought to enforce the terms of this Warrant will be brought in the appropriate federal or state court having jurisdiction over Clark
County, Nevada, United States of America.

 

    	12

     

    

 

(f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant will have restrictions
upon resale imposed by state and federal securities laws.

 

(g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that
all rights to exercise this warrant hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply
with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those
of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights,
powers or remedies hereunder.

 

(h)
Notices. All notices and other communications provided for hereunder shall be (i) in writing (including facsimile and email) and
(ii) sent by facsimile, email or overnight courier (if for inland delivery) or international courier (if for overseas delivery) to a
party hereto at its address and contact number specified below, or at such other address and contact number as is designated by such
party in a written notice to the other parties hereto:

 

	 	If to Company: 	 
	 	 	 	 
	 	 	Nestbuilder.com
    Corp.	 
	 	 	201
    W. Passaic Street, Suite 301	 
	 	 	Rochelle
    Park, NJ 07662	 
	 	 	Attention: Alex Aliksanyan	 
	 	 	Email:
____________________    	 
	 	 	 	 
	 	If to Holder: 	 
	 	 	 	 
	 	 	_________________________	 
	 	 	_________________________	 
	 	 	_________________________	 
	 	 	Email:
____________________    	 

 

(i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.

 

(j)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.

 

(k)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.

 

(l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.

 

(m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.

 

(n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.

 

(Signature
Page Follows)

 

    	13

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.

 

	Dated:
    February 4, 2022	COMPANY:
	 	 
	 	Nestbuilder.com Corp.,
	 	a Nevada corporation
	 	 	 
	 	By:	
	 	Name:	Alex Aliksanyan
	 	Title:	Chief
    Executive Officer

 

    	14

     

    

 

NOTICE
OF EXERCISE

 

TO:
NESTBUILDER.COM CORP.

 

(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)
Payment shall take the form of (check applicable box):

 

[  
] in lawful money of the United States; or

 

[  
] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
3(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 3(c).

 

(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

____________________

 

The
Warrant Shares shall be delivered to the following DWAC Account Number:

 

____________________

 

____________________

 

____________________

 

(4)
Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.

 

[SIGNATURE
OF HOLDER]

 

Name
of Investing Entity: ___________________________________________________________________________

Signature
of Authorized Signatory of Investing Entity: _____________________________________________________

Name
of Authorized Signatory: _______________________________________________________________________

Title
of Authorized Signatory: ________________________________________________________________________

Date:
___________________________________________________________________________________________

 

    	 

     

    

 

ASSIGNMENT
FORM

 

(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	 
	 	(Please
    Print)
	Address:	 
	 	(Please
    Print)
	Phone
    Number:	 
	Email
    Address	 
	Dated:
    ______________________ __, ______	 
	Holder’s
    Signature: ______________________	 
	Holder’s
    Address: _______________________Exhibit
10.7

 

FORM OF NOTE
CONVERSION AND WARRANT AMENDMENT AGREEMENT

 

This
Note Conversion and Warrant Amendment Agreement (this “Agreement”) is entered into as of February 7, 2022 (the “Effective
Date”) by and between Nestbuilder.com Corp., a Nevada corporation (the “Company”), and the party listed
on the signature page attached hereto (the “Note Holder” or “Holder”).

 

Recitals

 

WHEREAS,
the Company and the Note Holder entered into a certain Securities Purchase Agreement dated as of December 10, 2020, as amended (the “SPA”),
pursuant to which the Company sold and the Note Holder purchased a 10% senior convertible promissory note in the principal amount of
up to $10,000, convertible into shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”),
at a conversion price of $0.07 per share (the “Note”) and a common stock purchase warrant to purchase up to 50,000
shares of the Common Stock at an exercise price of $0.10 per share (the “Warrant”);

 

WHEREAS,
the Note Holder desires to convert and cancel all indebtedness of the Company under the Note held by the Note Holder, including any accrued
and unpaid interest or penalties under the Note, as set forth on Schedule A attached hereto, and the Company desires to issue
to the Note Holder in exchange for the cancellation of all indebtedness of the Company to such Note Holder, including any accrued and
unpaid interest or penalties under the Note, and for no additional consideration, the number of shares of Common Stock described in Section
2(a) (collectively, the “Note Conversion Shares”); and

 

WHEREAS,
in connection with the cancellation of the Note and issuance of the Note Conversion Shares, the Company and the Note Holder desire to
amend the Warrant to reduce the exercise price per share.

 

NOW,
THEREFORE, in consideration of the rights and benefits that they will each receive in connection with this Agreement, the parties,
intending to be legally bound, agree as follows:

 

1.
Defined Terms. Terms capitalized herein and not otherwise defined herein shall have the meanings ascribed to such terms in the
SPA.

 

2.
Cancellation of Note; Issuance of Note Conversion Shares.

 

a)
Note Conversion. Subject to the terms and conditions of this Agreement, on the Effective Date, the Company shall issue to the
Note Holder, in exchange for the cancellation of all indebtedness of the Company to the Note Holder, including any accrued and unpaid
interest or penalties under the Note held by the Note Holder and for no additional consideration, such number of Note Conversion Shares
equal to the amount determined by dividing the outstanding balance under the Note plus the accrued and unpaid interest as of the Effective
Date by $0.07 (the “Note Conversion”). From and after the Note Conversion, the Note converted shall solely represent
the right to receive the Note Conversion Shares hereunder, no amounts shall remain outstanding under such Note and such Note shall be
cancelled and otherwise be of no further force or effect.

 

    	1

    	 

    

 

b)
Delivery of Note. The Note Holder shall deliver its physical Note (or if such Note is lost, mutilated or destroyed or the Note
Holder is not able to easily obtain the Note, a lost note affidavit and indemnity agreement in a form reasonably acceptable to the Company
(each, an “Affidavit”)) to the Company for cancellation.

 

c)
Delivery of Shares. Within five (5) Business Days from the receipt of all duly executed documentation and receipt of the physical
Note (or Affidavit, as applicable) from the Note Holder, the Company shall deliver the applicable Note Conversion Shares to the Note
Holder in accordance with Section 2(a).

 

3.
Warrant Amendment. Subject to the terms and conditions of this Agreement, on the Effective Date, the following amendments will
be automatically made to each Warrant held by the Note Holder (the “Warrant Amendment”):

 

	 	a)	The
    introductory paragraph of each Warrant held by the Note Holder shall be automatically amended to provide that the exercise price
    per share shall be reduced from $0.10 per share to $0.02 per share. 
	 	 	 
	 	b)	Section
    1 of each Warrant held by the Note Holder shall be automatically amended to provide that the vesting deadline shall be changed from
    December 31, 2021 to January 5, 2022.
	 	 	 
	 	c)	Section
    4 of each Warrant held by the Note Holder shall be automatically amended to increase the Exercise Limitation from 4.99% of the Company’s
    outstanding common stock to 9.99% of the Company’s outstanding common stock.

 

No
other terms of the Warrant are being amended, and the Warrant shall remain otherwise in full force and effect.

 

4.
Representations and Warranties of the Company. The Company hereby represents and warrants to the Note Holder as of the date hereof
as follows:

 

a)
Organization and Standing. The Company is a corporation duly organized, validly existing under, and by virtue of, the laws of
the State of Nevada, and is in good standing under such laws.

 

b)
Corporate Power. The Company has all requisite legal and corporate power and authority to execute and deliver this Agreement,
to sell and issue the Note Conversion Shares hereunder, and to carry out and perform its obligations under the terms of this Agreement
and the transactions contemplated hereby.

 

    	2

    	 

    

 

c)
Authorization. All corporate action on the part of the Company, its officers, directors and shareholders necessary for the authorization,
execution, delivery and performance of this Agreement, the authorization, sale, issuance and delivery of the Note Conversion Shares and
the performance of all of the Company’s obligations hereunder have been taken or will be taken prior to or on the date hereof.
This Agreement has been duly executed by the Company and constitutes a valid and legally binding obligation of the Company, enforceable
against the Company in accordance with its terms, subject to the laws of general application relating to bankruptcy, insolvency and the
relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies.

 

d)
Valid Issuance of Stock. The Note Conversion Shares, when issued, sold and delivered in compliance with the provisions of this
Agreement, will be duly and validly issued, fully paid and non-assessable and issued in compliance with applicable federal and state
securities laws. Such Note Conversion Shares will also be free and clear of any liens or encumbrances; provided, however, that the Note
Conversion Shares shall be subject to the provisions of this Agreement and restrictions on transfer under state and/or federal securities
laws. The Note Conversion Shares are not subject to any preemptive rights, rights of first refusal or restrictions on transfer.

 

e)
Governmental Consents. No consent, approval, qualification or authority of, or registration or filing with, any local, state or
federal governmental authority on the part of the Company is required in connection with the valid execution, delivery or performance
of this Agreement, or the offer, sale or issuance of the Note Conversion Shares, or the consummation of any transaction contemplated
hereby, except (i) such filings as have been made prior to the date hereof and (ii) such additional post-closing filings as may be required
to comply with applicable federal and state securities laws (including but not limited to any Form D or Form 8-K filings), and with applicable
general corporation laws of the various states, each of which will be filed with the proper authority by the Company in a timely manner.

 

5.
Representations and Warranties of the Note Holder. The Note Holder hereby represents and warrants as of the date hereof to the
Company as follows:

 

a)
Organization and Standing. The Note Holder is either an individual or an entity duly organized, validly existing under, and by
virtue of, the laws of the jurisdiction of its incorporation or formation, and is in good standing under such laws.

 

b)
Corporate Power. The Note Holder has all right, corporate, partnership, limited liability company or similar power and authority
to execute and deliver this Agreement, to effect the Note Conversion hereunder, and to carry out and perform its obligations under the
terms of this Agreement and the transactions contemplated hereby.

 

c)
Authorization. All corporate, partnership, limited liability company or similar action, as applicable on the part of the Note
Holder, necessary for the authorization, execution, delivery and performance of this Agreement, the Note Conversion, the Warrant Amendment
and the performance of all of the Note Holder’s obligations hereunder have been taken or will be taken prior to the Effective Date.
This Agreement has been duly executed by the Note Holder and constitutes a valid and legally binding obligation of the Note Holder, enforceable
against the Note Holder in accordance with its terms, subject to the laws of general application relating to bankruptcy, insolvency and
the relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies.

 

    	3

    	 

    

 

d)
Governmental Consents. No consent, approval, qualification or authority of, or registration or filing with, any local, state or
federal governmental authority on the part of the Company is required in connection with the valid execution, delivery or performance
of this Agreement, or the offer, sale or issuance of the Note Conversion Shares, or the Warrant Amendment or the consummation of any
transaction contemplated hereby, except such filings as have been made prior to the date hereof.

 

e)
Own Account. The Note Holder understands that the Note Conversion Shares are “restricted securities” and have not
been registered under the Securities Act or any applicable state securities law in reliance upon exemptions from regulation for non-public
offerings and is acquiring the Note Conversion Shares as principal for its own account and not with a view to or for distributing or
reselling such Note Conversion Shares or any part thereof in violation of the Securities Act or any applicable state securities law,
has no present intention of distributing any such Note Conversion Shares in violation of the Securities Act or any applicable state securities
law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of
such Note Conversion Shares in violation of the Securities Act or any applicable state securities law. The Note Holder agrees that the
Note Conversion Shares or any interest therein will not be sold or otherwise disposed of by the Note Holder unless the shares are subsequently
registered under the Securities Act and under appropriate state securities laws or unless the Company receives an opinion of counsel
satisfactory to it that an exception from registration is available.

 

f)
Note Holder Status. The Note Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated
under the Securities Act. The Note Holder agrees to provide any additional documents and information that the Company shall reasonably
request for purposes of determining whether the Note Holder is an accredited investor. The Note Holder is not required to be, and certifies
that it is not, registered as a broker-dealer or registered representative under Section 15 of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”).

 

g)
Experience of Note Holder. The Note Holder, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Note Conversion Shares, and has so evaluated the merits and risks of such investment.

 

h)
Ability to Bear Risk. The Note Holder understands and acknowledges that investment in the Company is highly speculative and involves
substantial risks. The Note Holder is able to bear the economic risk of an investment in the Note Conversion Shares and is able to afford
a complete loss of such investment.

 

i)
General Solicitation. The Note Holder is not accepting the Note Conversion Shares or the Warrant Amendment as a result of any
advertisement, article, notice or other communication regarding the Note Conversion Shares or the Warrant Amendment published in any
newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation
or general advertisement.

 

    	4

    	 

    

 

j)
Disclosure of Information. The Note Holder has had the opportunity to receive all additional information related the Company requested
by it and to ask questions of, and receive answers from, the Company regarding the Company, including the Company’s business management
and financial affairs, and the terms and conditions of this offering of the Note Conversion Shares and Warrant Amendment. Such questions
were answered to the Note Holder’s satisfaction. The Note Holder has also had access to copies of the Company’s filings with
the U.S. Securities and Exchange Commission under the Securities Act and Exchange Act. The Note Holder believes that it has received
all the information the Note Holder considers necessary or appropriate for deciding whether to consummate the Note Conversion and Warrant
Amendment. The Note Holder understands that such discussions, as well as any information issued by the Company, were intended to describe
certain aspects of the Company’s business and prospects, but were not necessarily a thorough or exhaustive description.

 

k)
Residency. The residency of the Note Holder (or in the case of a partnership or corporation, such entity’s principal place
of business) is correctly set forth on the signature page attached hereto.

 

l)
Tax Matters. The Note Holder has reviewed with its own tax advisors the U.S. federal, state, local and foreign tax consequences
of this investment and the transaction contemplated by this Agreement. The Note Holder understands that it (and not the Company) shall
be responsible for its own tax liability that may arise as a result of this investment and the transactions contemplated by this Agreement.

 

m)
Restrictions on Transferability; No Endorsement. The Note Holder has been informed of and understand the following:

 

	 	i.	There
    are substantial restrictions on the transferability of the Note Conversion Shares; or
	 	 	 
	 	ii.	No
    federal or state agency has made any finding or determination as to the fairness for public investment, nor any recommendation nor
    endorsement of the Note Conversion Shares.

 

n)
No Other Representation by the Company. None of the following information has ever been represented, guaranteed or warranted to
the Note Holder, expressly or by implication by any broker, the Company, or agent or employee of the foregoing, or by any other Person:

 

	 	i.	The
    approximate or exact length of time that the Note Holder will be required to remain a holder of the Note Conversion Shares;
	 	 	 
	 	ii.	The
    amount of consideration, profit or loss to be realized, if any, as a result of an investment in the Company; or

 

    	5

    	 

    

 

	 	iii.	that
    the past performance or experience of the Company, its officers, directors, associates, agents, affiliates or employees or any other
    person will in any way indicate or predict economic results in connection with the plan of operations of the Company or the return
    on investment.

 

6.
Waiver. Effective immediately upon the Note Conversion with respect to the Note and Warrant held by the Note Holder, the Note
Holder expressly forfeits and waives any and all rights that are inconsistent with the terms of this Agreement either under the SPA,
the Warrant, the Note or otherwise applicable to the Note, including, but not limited to, any anti-dilution rights the Note Holder may
have with respect to the issuances of any capital stock or other securities of the Company pursuant to previous transactions and pursuant
to this Agreement.

 

7.
Miscellaneous.

 

	 	a)	Legends.

 

	 	i.	The
    Note Holder hereby acknowledges that any certificates representing any of the Note Conversion Shares shall bear a restricted security
    legend substantially in the following form (in addition to any legend required by applicable state securities or “blue sky”
    laws):

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY BE OFFERED, SOLD, ASSIGNED, PLEDGED, HYPOTHECATED, TRANSFERRED OR OTHERWISE
DISPOSED OF (EACH, A “TRANSFER”) ONLY IF SUCH SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE
SECURITIES LAWS OR IF SUCH TRANSFER IS MADE PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND SUCH STATE SECURITIES
LAWS AFTER PROVIDING AN OPINION OF COUNSEL TO SUCH EFFECT.”

 

	 	ii.	The
    Note Holder hereby acknowledges and agrees to the Company making a notation on its records or giving instructions to the registrar
    and transfer agent of the Company (along with any successor transfer agent of the Company) in order to implement the restrictions
    on transfer set forth and described in this Agreement.

 

b)
Reliance on Representations and Warranties by the Company. The Note Holder acknowledges that the representations and warranties
contained herein are made by it with the intention that such representations and warranties may be relied upon by the Company and its
legal counsel in determining the Note Holder’s eligibility to purchase the Note Conversion Shares under applicable securities legislation,
or (if applicable) the eligibility of others on whose behalf it is contracting hereunder to purchase the Note Conversion Shares under
applicable securities legislation. The Note Holder further agrees that the representations and warranties made by the Note Holder will
survive the Note Conversion and Warrant Amendment and will continue in full force and effect notwithstanding any subsequent disposition
of the Note Holder of such Note Conversion Shares.

 

    	6

    	 

    

 

c)
Fees and Expenses. Each party shall pay the fees and expenses of its advisors, counsel, accountants and other experts, if any,
and all other expenses incurred by such party incident to the preparation, execution, delivery and performance of this Agreement.

 

d)
Entire Agreement. This Agreement, together with the schedules and exhibits attached hereto, contain the entire agreement of the
parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written with respect
to such matters. To the extent that any provision of the SPA, the Note, or the Warrant are inconsistent with the provisions of this Agreement,
the provisions of this Agreement shall control.

 

e)
Notices. All notices, demands requests, consents, approvals, and other communications required or permitted hereunder shall be
in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified,
return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, facsimile or electronic mail, addressed as set forth below or to such other address as such party shall have
specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed
effective (a) upon hand delivery or delivery by facsimile or electronic mail, with delivery receipt or the affidavit of messenger, at
the address, number or electronic mail address designated below (if delivered on a Business Day during normal business hours where such
notice is to be received), or the first Business Day following such delivery (if delivered other than on a Business Day during normal
business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier
service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall occur first. The addresses
for such communications shall be: (i) if to the Company, to: Nestbuilder.com Corp., Attn: Chief Executive Officer, 201 W. Passaic Street,
Suite 301, Rochelle Park, NJ 07662, and (iii) if to the Note Holder, to the address, fax number and e-mail as indicated on the signature
page attached hereto.

 

f)
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and the Note Holder. No waiver with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.

 

g)
Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.

 

h)
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns.

 

    	7

    	 

    

 

i)
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

j)
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement and the transactions
contemplated hereby shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without
regard to the principals of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
of Nevada. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts of Nevada for the adjudication
of any dispute hereunder or in connection herewith or the transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not an appropriate venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof.

 

k)
Survival. The representations and warranties contained herein shall survive the Effective Date for the applicable statute of limitations.

 

l)
Execution. This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one
and the same agreement, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission or by email delivery of a “.pdf” format data file, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile
or “.pdf” signature was an original thereof.

 

m)
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ, an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.

 

n)
Construction. The parties hereto agree that each of them and/or their respective counsel have reviewed and have had an opportunity
to revise this Agreement and the schedules and exhibits attached hereto. This Agreement shall be construed according to its fair meaning
and not strictly for or against any party. The word “including” shall be construed to include the words “without limitation.”
In this Agreement, unless the context otherwise requires, references to the singular shall include the plural and vice versa.

 

o)
Confidentiality. The Note Holder agrees to maintain the confidentiality of all of the terms and conditions of this Agreement (the
“Information”), except that Information may be disclosed (a) to its and its affiliates’ directors, officers,
employees and agents, including accountants, legal counsel and other advisors (it being understood that the persons to whom such disclosure
is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to
the extent requested by any regulatory authority, (c) to the extent required by applicable laws or regulations or by any subpoena or
similar legal process, (d) with the consent of the Company or (e) to the extent such Information (i) becomes publicly available other
than as a result of a breach of this Section 7(o) or (ii) becomes available to the Note Holder on a non-confidential basis from a source
other than the Company.

 

p)
Acknowledgment of Concurrent Negotiations. The Note Holder acknowledges that they have been informed that the Company is currently
negotiating with other holders of the Note and Warrant and that the terms being offered to those holders may be more favorable than the
terms set forth in this Agreement.

 

q)
WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

[Signature
Page Follows]

 

    	8

    	 

    

 

IN
WITNESS WHEREOF, the parties have caused this Note Conversion and Warrant Amendment Agreement to be duly executed and delivered as of
the date and year first written above.

 

	 	“Company”
	 	 
	 	Nestbuilder.com
                                            Corp.,

    a
    Nevada corporation

	 	 
	 	By:	 
	 	Name: 	Alex
    Aliksanyan
	 	Title:	Chief
    Executive Officer

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties have caused this Note Conversion and Warrant Amendment Agreement to be duly executed and delivered as of
the date and year first written above.

 

	 	“Note
    Holder”
	 	 	 
	 	Address
    for Notice: 	 
	 		 
	 		 
	 	E-mail
    address:	 
	 	 	 
	 	If
    by an individual:
	 	 	 
	 	By:
    	 
	 	Printed
    Name: 	 
	 	State
    Residency: 	 
	 	 	 
	 	If
    by an entity:
	 	 	 
	 	Name
    of Entity: 	 
	 	By:
    	 
	 	Printed
    Name: 	 
	 	Title:
    	 
	 	Principal Place of Business:
	 	 	 

 

[Signature
Page to Note Conversion and Warrant Amendment Agreement]

 

    	 

    	 

    

 

SCHEDULE
A

 

	 

    Note
    Holder
	 	Principal
    Amount of Note	 	Accrued
    Interest	 	Total
    Principal and Interest	 	Note
    Conversion Shares

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]